October 5. Interfax-Russia.ru – Russia needs to adopt a program to combat hepatitis in order to fulfill the decision, head of the laboratory of viral hepatitis at the Mechnikov Research Institute of Vaccines and Serums, Vladimir Mikhailov.
“There should be a budget program at the federal and regional levels to control viral hepatitis.
At the same time, according to Mikhailov, a program to combat hepatitis C is being prepared in the Russian Federation. Scientist that it detects the disease in a timely manner – at present, a significant part of people do not know that they have chronic hepatitis, in the last two years attention has been focused on combating coronavirus infection.
At the same time, the head of the laboratory clarified that the coronavirus is not aggravated by hepatitis, despite the fact that the coronavirus can attach, inter alia, to the receptors of liver cells and cause immunodeficiency states.
“This all suggests that we must not postpone the treatment of hepatitis and deal with coronavirus infection,” he said.
Meanwhile, in general, the situation with hepatitis in the Russian Federation is quite calm, Mikhailov said. “We do not have the same catastrophe, the situation is the same as two years ago,” he said.
The incidence of hepatitis A is very low, the lowest in the last 10 years. The incidence of hepatitis B is the lowest in the last 20 years, due to vaccination. Effective drugs are used against hepatitis C, a vaccine for which cannot be created due to the variability of the pathogen.
Mikhailov recalled that about five years ago in Tuva, a universal vaccination of children and adolescents was carried out – more than 40 thousand people – against hepatitis A, as a result, there has been no hepatitis A in the republic over the past years.
At the same time, hepatitis E occurs, occurs, but the problem is aggravated by the fact that it can be transmitted from piglets, the scientist notes. At the same time, according to him, the genotype circulating in the Russian Federation does not cause deaths in pregnant women, like other genotypes of the virus. At the same time, severe forms of hepatitis E, as well as chronic ones, are possible.
In addition, a drug has been developed for hepatitis “delta”, which is widespread, for example, in Yakutia.
In total, there are about 6 million chronic hepatitis of various types in the Russian Federation, Mikhailov said.
Interfax is an information partner of the OpenBio-2021 forum.